Tata India Pharma & Healthcare Fund-Direct Plan-Growth

As on 27 Jun 2025

logo

Tata India Pharma & Healthcare Fund-Direct Plan-Growth

Equity

NAV

34.75

CAGR (3 Years)

26.42%

AUM (Cr)

1,231.67

Risk

Very High Risk

About Tata India Pharma & Healthcare Fund-Direct Plan-Growth

To seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sector in India.

Breakdown of this Fund

logo
Chemicals
0.57%
logo
Debt Others
15.74%
logo
Fertilizers
2.21%
logo
Healthcare
52.92%
logo
IT - Software
1.01%
logo
Miscellaneous
3.22%
logo
Pharmaceuticals
96.11%
logo
Retail
1.71%

Market Capitalization

Get your FAQs right

What kind of returns does Tata India Pharma & Healthcare Fund-Direct Plan-Growth provide?

plus

How much expense ratio is charged by Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

What is the AUM of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

What is the NAV of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

What is the PE and PB ratio of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

What is the exit load of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions